Drug intelligence / Profile preview

Muno-IgY

Development stage
Preclinical
Lead developer
IGY Immune Technologies & Life Sciences
Modality
Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

**Muno-IgY** is an ultra-pure, all-natural antibody-based supplement derived from hen egg yolk, containing immunoglobulin Y (IgY) antibodies. These antibodies target and bind pathogenic microbes and toxins in the gastrointestinal tract, helping neutralize and remove unwanted bacteria while preserving beneficial commensal flora[3][5][2]. The mechanism of action is passive immunization at the gut mucosa; IgY inhibits microbial adhesion, induces pathogen agglutination, neutralizes toxins, and supports barrier integrity[3][2][6]. The supplement shows potential for improving immune and gut health, reducing upper respiratory tract infection rates, and managing gut dysbiosis and leaky gut syndrome[3][5]. Muno-IgY is developed and manufactured by IGY Immune Technologies & Life Sciences, which uses a proprietary process for high-purity extraction. It is marketed for dietary supplement use and designated self-affirmed GRAS for safety as per US Title 21 Code of Federal Regulations[2]. Clinical studies in healthy adults have been conducted to assess safety, effectiveness, and bioavailability[1][7].

Brand names
Muno-IgYIGY Daily Immune Defense
Other names
Immunoglobulin YIgYMuno-IgY egg protein isolate
02

Targets

Flagellin

Beyond the preview

Go deeper on Muno-IgY.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muno-IgY.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call